Point Therapeutics Report issue

For profit Phase 2 Phase 3
Founded: Wellesley Hills MA United States (1993)
Status: Acquired by DARA Therapeutics (2008) → now Midatech Pharma (2015)

Organization Overview

First Clinical Trial
2004
NCT00080080
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2006

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree